HIGHLIGHTS
- who: Cédric Chauvierre et al. from the AP-HP, Department of Nuclear Medicine, XBichat Hospital, Paris, France Nanomedicine Research and Education Center, Semmelweis University, Budapest, Hungary have published the research work: Pharmaceutical Development and Safety Evaluation of a GMP-Grade Fucoidan for Molecular Diagnosis of Cardiovascular Diseases, in the Journal: (JOURNAL) of 24/02/1987
- what: This study describes the pharmaceutical development safety evaluation and preclinical efficacy of a micro-dosed radiotracer. Since nuclear imaging with single-photon emission computed tomography (SPECT) allows for in_vivo molecular imaging with high sensitivity, the authors propose 99m . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.